New study aims to tailor sickle cell drug dosing for nigerian patients
Knowledge-focused
Not yet recruiting
This study will look at how genetics and body processes affect the way Nigerian patients with sickle cell disease respond to the drug hydroxyurea. Researchers will study 100 patients to create a computer model that can help doctors choose the best dose for each person. The goal i…
Sponsor: Ochuko Orherhe • Aim: Knowledge-focused
Last updated May 15, 2026 11:40 UTC